The pharmaceutical industry's response to the Covid-19 outbreak has been marked by a strong spirit of solidarity and by joining forces with governments to drive the development of diagnostics, medicines and vaccines. As a company specialised in pain, our research teams remain focused on developing life-changing pain treatments, while our production teams are working hard to secure a continuous supply of our medicines to patients worldwide.
At the same time, our management team is constantly focused on making sure our employees stay safe and healthy.
Grünenthal and our employees around the world have stepped up support for healthcare systems, communities and individuals during the Covid-19 outbreak – from fund raising through to donating medicines, masks and medical expertise. Here are some examples of our initiatives.
Supporting our communitiesGrünenthal has a long track record of supporting projects that have a positive impact on people and communities worldwide. Many of our employees actively engage in local projects and have recently strengthened this engagement to address Covid-19.
All of us at Grünenthal will continue to do everything we can to protect our employees and their families, and to help patients as well as the communities we operate in.
Stay healthy and safe!